FDA Orange Book
Is there a generic for Camcevi Kit?
Camcevi Kit contains leuprolide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Camcevi Kit (leuprolide). The Orange Book shows its last listed patent expires January 1, 2039.
Run it in Rivvi
Map Camcevi Kit and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Camcevi Kit products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| emulsion, subcutaneous | EQ 42MG BASE | Marketed (Rx) | None | 0 | None |
NDA 211488, held by ACCORD BIOPHARMA INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Camcevi Kit patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10646572 | January 16, 2027 | Drug product | None | 211488 |
| 9744207 | January 16, 2027 | Drug product | None | 211488 |
| 9572857 | August 2, 2029 | Drug product | None | 211488 |
| 12133878 | December 18, 2037 | Drug product | None | 211488 |
| 11717555 | January 1, 2039 | Drug product | None | 211488 |
Camcevi Kit NDC codes
Questions
Is there a generic for Camcevi Kit?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Camcevi Kit (leuprolide). The Orange Book shows its last listed patent expires January 1, 2039.
What is the generic name for Camcevi Kit?
The active ingredient in Camcevi Kit is leuprolide, per the FDA Orange Book.
When does the Camcevi Kit patent expire?
The last patent listed for Camcevi Kit in the Orange Book expires January 1, 2039. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.